The EDQM’s Biological Standardisation Programme, a joint programme of the Council of Europe and the European Commission, has recently run a study to establish batch 2 of the European Pharmacopoeia (Ph. Eur.) Human anti-D immunoglobulin Biological Reference Preparation (BRP). The outcome of the establishment study has been published in the online journal Pharmeuropa Bio & Scientific Notes.
The batch was adopted by the European Pharmacopoeia Commission in October 2024 and will be available for purchase once stocks of batch 1 are depleted (catalogue number Y0000219).
Pharmeuropa Bio & Scientific Notes is published by the EDQM and referenced on MedLine.